Skip to main content
NMMCF logo

NMC Health plc (NMMCF) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.000001 $0.00 (0.00%)
P/E Ratio: 0.00| Vol: 131| 52-wk range: $0.000001 – $0.0001

P/E 0.00 means the share price is 0.00 times one year of earnings per share.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

NMC Health plc (NMMCF) trades at $0.000001. NMC Health plc is an international healthcare services provider operating hospitals, medical centers, and specialized clinics across the UAE, UK, and Spain. Sector: Healthcare.

Price as of · Last analyzed: Jun 15, 2026
NMC Health plc is an international healthcare services provider operating hospitals, medical centers, and specialized clinics across the UAE, UK, and Spain. The company offers a diverse range of medical services, including diagnostics, inpatient and outpatient care, and fertility treatments, alongside facility management and pharmaceutical retail.

Analyst Coverage for NMMCF: NMMCF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • HCA · HCA Healthcare, Inc. · 77 /100
  • THC · Tenet Healthcare Corporation · 94 /100
  • SOLV · Solventum Corporation · 66 /100

See all scored stocks →

NMC Health plc (NMMCF) Healthcare & Pipeline Overview

CEODavid J. Hadley
Employees17,748
HeadquartersLondon, GB
IPO Year2018

NMC Health plc is an international healthcare services provider managing a diverse portfolio of medical facilities, including hospitals, clinics, and specialized centers across the UAE, UK, and Spain. Leveraging its established presence and comprehensive service offerings, the company addresses broad healthcare needs within its operating regions.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 15, 2026

What Is the Investment Thesis for NMMCF?

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

NMC Health plc operates within the perpetually growing global healthcare sector, offering a diversified portfolio of medical facilities and services across key international markets including the UAE, UK, and Spain. The fundamental demand for healthcare services, driven by demographic shifts and evolving medical needs, provides a robust underlying market for the company’s operations, which span general hospitals, specialized clinics, and long-term care facilities. With 17,748 employees, NMC Health plc possesses a significant operational scale and an established presence in its regions. However, investors must critically assess the company's current market capitalization of $0.00B and a Beta of -2.21, which indicate severe financial distress, potential delisting, or ongoing restructuring. These metrics suggest substantial risks and necessitate thorough due diligence into the company's financial stability and future viability. The company’s comprehensive service offerings, from diagnostics to specialized fertility treatments and home health, represent potential value drivers if a successful financial restructuring or operational turnaround can be achieved, allowing it to capitalize on the sustained demand for healthcare.

Based on FMP financials and quantitative analysis

NMMCF Key Highlights

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Market Capitalization: $0.00B, indicating severe financial distress or delisting from major exchanges.

  • Beta: -2.21, suggesting a highly unusual inverse correlation or extreme volatility relative to the broader market, often associated with distressed assets.
  • Employee Base: Operates with a significant workforce of 17,748 employees across its various healthcare facilities.
  • Geographic Footprint: Established operations in the United Arab Emirates, the United Kingdom, Spain, and other international markets.
  • Service Diversification: Comprehensive healthcare offerings include hospitals, medical centers, long-term care, day surgery, fertility clinics, and home health services.

Who Are NMMCF's Competitors?

NMMCF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
HCA HCA Healthcare, Inc. $476.35 -4.96% $99.5B 77 5-pillar
THC Tenet Healthcare Corporation $271.34 -3.80% $21.6B 94 5-pillar
SOLV Solventum Corporation $86.48 +0.49% $14.7B 66 5-pillar
EHC Encompass Health Corporation $134.94 -2.13% $13.2B 81 5-pillar
FMS Fresenius Medical Care AG & Co. KGaA $20.95 -3.41% $10.9B 80 5-pillar
UHS Universal Health Services, Inc. $186.07 -3.08% $10.7B 91 5-pillar
ENSG The Ensign Group, Inc. $182.98 -1.63% $10.7B 74 5-pillar
DVA DaVita Inc. $161.75 -6.50% $10.2B 76 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are NMMCF's Key Strengths?

Extensive international presence across the UAE, UK, and Spain, diversifying market exposure.

  • Comprehensive portfolio of healthcare facilities and services, including specialized care and home health.
  • Established operational history since 1974, indicating long-standing industry experience.
  • Significant employee base of 17,748, reflecting substantial operational capacity.

What Are NMMCF's Weaknesses?

Current market capitalization of $0.00B, indicating severe financial distress or delisting.

  • Negative Beta of -2.21, suggesting extreme volatility or an inverse relationship with the broader market.
  • Trading on the OTC Other tier with an unknown disclosure status, leading to limited transparency and regulatory oversight.
  • Potential for operational inefficiencies or legacy issues given its long history and current financial state.

What Are the Key Risks for NMMCF?

Financial-distress signal — its Altman Z-Score of 1.01 sits in the distress zone (elevated bankruptcy risk).

  • Zero Market Capitalization: The reported $0.00B market cap indicates severe financial distress, potential delisting, or ongoing liquidation, posing an existential risk to equity holders.
  • Negative Beta of -2.21: This highly unusual metric suggests extreme volatility or an inverse correlation to the market, often seen in highly distressed or speculative assets, indicating significant investment risk.
  • OTC Other Tier and Unknown Disclosure: Trading on the lowest OTC tier with no public disclosures creates extreme transparency risks, making fundamental analysis and valuation impossible.
  • Regulatory and Legal Challenges: Operating across multiple international jurisdictions exposes the company to diverse and evolving healthcare regulations, which could impact profitability and compliance.
  • Intense Competition: The healthcare facilities sector is competitive, and NMC Health plc faces ongoing pressure from other providers in its key markets, potentially impacting patient volumes and pricing power.

What Threats Does NMMCF Face?

  • Intense competition from other established and emerging healthcare providers in its operating regions.
  • Adverse changes in healthcare regulations, reimbursement policies, or government spending in key markets.
  • Economic downturns or geopolitical instability impacting healthcare spending and patient volumes.
  • Reputational damage or loss of patient trust due to financial distress or operational challenges.

What Are NMMCF's Competitive Advantages?

  • Established International Presence: Operates a network of facilities across multiple countries (UAE, UK, Spain), providing geographic diversification and market access.
  • Diversified Service Portfolio: Offers a broad range of healthcare services from general medicine to specialized fertility and long-term care, catering to varied patient needs.
  • Operational Scale: Manages a significant number of employees (17,748), indicating substantial operational capacity and an ability to handle large patient volumes.
  • Integrated Healthcare Model: Combines facility ownership, direct medical services, facility management, and pharmaceutical retail, creating a comprehensive healthcare ecosystem.

What Does NMMCF Do?

NMC Health plc, founded in 1974 and headquartered in London, United Kingdom, has evolved into an international provider of comprehensive healthcare services. The company's operational footprint extends across the United Arab Emirates, the United Kingdom, Spain, and other international markets, where it owns and manages a diverse portfolio of healthcare facilities. This extensive network includes general hospitals, specialized medical centers, long-term care facilities, day surgery centers, and advanced fertility clinics, alongside home health services providers. NMC Health plc is deeply involved in the direct provision of medical services, encompassing a wide array of diagnostic capabilities and both inpatient and outpatient care options. Beyond general medical practice, the company has developed specific expertise and research capabilities in critical areas such as gynecology, obstetrics, and human reproduction, catering to a significant and specialized patient demographic. In addition to direct patient care, NMC Health plc also offers management services for hospitals, leveraging its operational experience to optimize performance for other healthcare entities. Furthermore, the company engages in the retail of pharmaceutical goods, providing a holistic approach to patient care and health management. With a substantial workforce of 17,748 employees, NMC Health plc is positioned as a significant player in the global healthcare facilities sector, aiming to deliver accessible and high-quality medical services across its diverse geographic segments.

What Products and Services Does NMMCF Offer?

  • Owns and manages a diverse portfolio of healthcare facilities, including hospitals, medical centers, and specialized clinics.
  • Provides comprehensive medical services, including diagnostic testing, inpatient care, and outpatient consultations.
  • Offers specialized medical services in gynecology, obstetrics, and human reproduction, including fertility clinics.
  • Provides long-term care facilities and day surgery centers for various medical needs.
  • Delivers home health services, extending medical care beyond traditional facility settings.
  • Offers management services for other hospitals, leveraging its operational expertise.
  • Engages in the retail of pharmaceutical goods, providing convenient access to medications for patients.

How Does NMMCF Make Money?

  • Generates revenue primarily through patient services, including consultations, procedures, and hospital stays.
  • Earns income from managing healthcare facilities for third-party clients.
  • Derives revenue from the retail sale of pharmaceutical products through its outlets.
  • Operates various specialized clinics, such as fertility centers, which often command premium service fees.
  • Provides long-term care and home health services, offering recurring revenue streams based on ongoing patient needs.

What Industry Does NMMCF Operate In?

NMC Health plc operates within the dynamic and essential global healthcare services industry, specifically focusing on medical care facilities. This sector is characterized by consistent demand driven by aging populations, increasing prevalence of chronic diseases, and advancements in medical technology. The company's presence in diverse markets like the UAE, UK, and Spain positions it within regions with varying healthcare systems and regulatory frameworks, yet all experiencing sustained demand for quality medical care. The competitive landscape for medical care facilities is fragmented, involving both large hospital chains and smaller specialized clinics. NMC Health plc distinguishes itself through its broad service offering, encompassing everything from general diagnostics and inpatient services to highly specialized areas like fertility and long-term care. The industry is currently seeing trends towards integrated care models, digital health adoption, and a focus on preventative medicine, which could influence future strategic directions for facility operators like NMC Health plc.

Who Are NMMCF's Key Customers?

  • Individual patients seeking general medical care, specialized treatments, or emergency services.
  • Patients requiring long-term care, rehabilitation, or home health support.
  • Couples and individuals seeking fertility treatments and reproductive health services.
  • Other healthcare organizations or investors seeking professional management services for their hospitals.
  • Consumers purchasing pharmaceutical goods through the company's retail channels.
Model self-rating on this text: 61% (not a measure of the evidence) Updated: Jun 15, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage
ROE 21%

Key Financial Metrics

Return on equity for NMC Health plc stands at 20.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.4%, showing how much profit it generates from its asset base. NMMCF trades at a trailing price-to-earnings ratio of 0.00, below the Healthcare sector average of ~21.70x. A current ratio of 1.45 indicates the company holds enough short-term assets to cover its near-term obligations.

Company Profile

NMC Health plc operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in London, GB. The company is led by CEO David J. Hadley. NMMCF has traded publicly since 2018.

F-Score 6/9

Financial Health

NMC Health plc's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.01 places it in the distress zone, a signal of elevated financial risk.

NMMCF Latest News

No recent news available for NMMCF.

NMMCF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for NMMCF.

Price Targets

Wall Street price target analysis for NMMCF.

NMMCF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for NMMCF; grades run from A+ (80-100) to F (below 30).

Leadership: David J. Hadley

CEO

The specific career history, educational background, and previous roles for David J.

Track Record: Details regarding David J. Hadley's key achievements, strategic decisions, or specific company milestones under his leadership at NMC Health plc are not available in the provided source data.

NMMCF OTC Market Information

NMC Health plc trades on the 'OTC Other' tier, which represents the lowest and most speculative segment of the OTC market. Unlike companies listed on major exchanges like NYSE or NASDAQ, or even higher OTC tiers like OTCQX or OTCQB, companies on 'OTC Other' are not required to meet minimum financial standards or file regular reports with the SEC. This tier typically includes companies that are distressed, defunct, or have very limited public information. It signifies a significantly higher risk profile compared to higher-tiered OTC markets, which often have some level of financial reporting or disclosure requirements, albeit less stringent than national exchanges. Investors in 'OTC Other' stocks face substantial challenges in obtaining reliable and timely company information.

  • OTC Tier: OTC Other
Liquidity: Given its 'OTC Other' tier classification and 'Unknown' disclosure status, NMC Health plc likely experiences extremely low liquidity. Trading volume is expected to be minimal, leading to wide bid-ask spreads, which can significantly impact execution prices for investors. The difficulty in buying or selling shares at a desired price is substantial, as there may be few buyers or sellers in the market at any given time. This illiquidity makes the stock highly challenging to trade and can exacerbate price volatility, particularly during periods of market stress or significant news.
OTC Risk Factors:
  • Lack of Transparency: Unknown disclosure status means no public financial reports, making it impossible to assess financial health or operational performance.
  • Extremely Low Liquidity: Trading on 'OTC Other' typically results in minimal trading volume and wide bid-ask spreads, making it difficult to buy or sell shares.
  • High Volatility and Price Manipulation: Low liquidity and limited information can lead to extreme price fluctuations and increased susceptibility to manipulation.
  • Limited Regulatory Oversight: 'OTC Other' tier has minimal regulatory requirements, offering investors little protection compared to major exchanges.
  • Potential for Delisting/Cessation of Trading: Companies in this tier, especially with a $0.00B market cap, face a high risk of ceasing public trading entirely.
Due Diligence Checklist:
  • Verify any available financial statements or reports, however limited, from independent sources.
  • Research the background and track record of current management, if any information can be found.
  • Investigate any legal proceedings, bankruptcy filings, or regulatory actions against the company.
  • Understand the current operational status of its healthcare facilities and services.
  • Assess the company's capital structure and any outstanding debt obligations.
  • Examine any news or press releases, even historical ones, for clues about its current situation.
  • Consult with legal or financial professionals experienced in distressed or OTC securities.
Legitimacy Signals:
  • Established Founding Year: Founded in 1974, indicating a long operational history.
  • Stated Employee Count: Reports 17,748 employees, suggesting a substantial operational scale.
  • Specific Business Operations: Clearly defined business of owning and managing healthcare facilities and providing medical services.
  • Geographic Reach: Operations across multiple countries (UAE, UK, Spain) suggest a historically significant presence.

NMC Health plc Healthcare Stock: Key Questions Answered

What are the key growth opportunities for NMMCF in healthcare?

NMC Health plc has several potential growth opportunities within the healthcare sector, assuming a stable operational and financial environment. One key area is the expansion of its specialized healthcare segments, such as fertility clinics and long-term care facilities, which are experiencing growing demand globally.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Market capitalization of $0.00B and Beta of -2.21 are direct facts from the source data and indicate severe financial distress or delisting. Implications are inferred neutrally.
  • CEO title 'CEO' is inferred based on 'managing 17748 employees' as the most probable leadership role.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

Stock Deep Dives